Bioxytran, Inc.
BIXT
$0.077
-$0.0068-8.12%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.10K | 4.30K | 5.20K | 34.70K | 13.50K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3.10K | 4.30K | 5.20K | 34.70K | 13.50K |
|
|
|||||
| Total Current Assets | 3.10K | 4.30K | 5.20K | 34.70K | 13.50K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 144.40K | 131.70K | 133.50K | 124.30K | 115.00K |
| Total Assets | 147.50K | 136.10K | 138.70K | 159.00K | 128.60K |
|
|
|||||
| Total Accounts Payable | -- | -- | 147.60K | -- | 2.70K |
| Total Accrued Expenses | 711.70K | 563.50K | 277.90K | 259.80K | 321.60K |
| Short-term Debt | 1.35M | 1.26M | 1.09M | 933.60K | 839.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 725.80K | 1.02M | 411.00K | 50.20K | 65.20K |
| Total Other Current Liabilities | 725.80K | 1.02M | 411.00K | 50.20K | 65.20K |
| Total Current Liabilities | 2.78M | 2.84M | 1.93M | 1.24M | 1.23M |
|
|
|||||
| Total Current Liabilities | 2.78M | 2.84M | 1.93M | 1.24M | 1.23M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.35M | 1.26M | 1.09M | 933.60K | 839.00K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.78M | 2.84M | 1.93M | 1.24M | 1.23M |
|
|
|||||
| Common Stock & APIC | 17.56M | 17.52M | 17.09M | 17.29M | 16.55M |
| Retained Earnings | -20.24M | -20.27M | -18.92M | -18.40M | -16.96M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -2.68M | -2.75M | -1.84M | -1.11M | -405.70K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 43.40K | 43.40K | 43.20K | 28.90K | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 43.40K | 43.40K | 43.20K | 28.90K | -- |
|
|
|||||
| Total Common Equity | -2.68M | -2.75M | -1.84M | -1.11M | -405.70K |
| Total Preferred Equity | 43.40K | 43.40K | 43.20K | 28.90K | -- |
| Total Minority Interest | -- | -- | -- | -- | -694.20K |
| Total Equity | -2.64M | -2.71M | -1.79M | -1.08M | -1.10M |
|
|
|||||